Targeted foreign gene expression in spinal cord neurons using poliovirus replicons

Journal of NeuroVirology

Volumn 6, Issue 2, 2000, Pages 95-105

  Bledsoe, Andrea W ^a   Gillespie, G Yancey ^b   Morrow, Casey D ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Neurons; Poliovirus replications; Spinal cord; Viral vector

Indexed keywords

LUCIFERASE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; ENZYME ACTIVITY; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REPLICON; SPINAL CORD NERVE CELL; TRANSGENIC MOUSE;

ANIMALIA; MIRIDAE; MUS MUSCULUS; POLIOVIRUS;

EID: 0034066767     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280009013153     Document Type: Article

References (26)

1. Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A (1995). Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 206: 1075-1083.
2. Ansardi DC, Porter DC, Morrow CD (1993). Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid precursor in trans. J Virol 67: 3684-3690.
3. Bartholdi D, Schwab ME (1997). Expression of proinflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9: 1422-1438.
4. Blesch A, Tuszynski MH (1997). Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol 148: 444-452.
5. Blondel B, Duncan G, Couderc T, Delepeyroux F, Panis N, Coldre-Gampan F (1998). Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells. J Neurovirol 4: 1-26.
6. Bodian D (1949). Histopathologic basis of clinical findings in poliomyelitis. Am J Med 6: 563-578.
7. Choi WS, Pal-Ghosh R, Morrow CD (1991). Expression of human immunodeficiency virus type 1 (HIV-1), gag, pol, and env proteins from chimeric HIV-1 poliovirus minireplicons. J Virol 65: 2875-2883.
8. Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ (1995). Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci USA 92: 1411-1415.
9. Deatly AM, Taffs RE, McAuliffe JM, Nawoschik SP, Coleman JW, McMullen G, Weeks-Levy C, Johnson AJ, Racaniello VR (1998). Characterization of mouse lines transgenic with the human poliovirus receptor gene. Microbiol Pathogen 25: 43-54.
10. Freistadt M (1994). Distribution of the poliovirus receptor in human tissue. In: Cellular receptors for animal viruses. Wimmer E (ed). Cold Springs Harbor Laboratory Press: New York, pp 445-461.
11. Freistadt MS, Kaplan G, Racaniello VR (1990). Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol 10: 5700-5706.
12. Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B (1999). Poliovirus induces apoptosis in the mouse central nervous system. J Virol 73: 6066-6072.
13. Hashimoto I, Hagiwara A, Komatsu T (1984). Ultrastructural studies on the pathogenesis of poliomyelitis in monkey infected with poliovirus. Acta Neuropathol 64: 53-60.
14. Holland JJ (1961). Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15: 312-326.
15. Jablonski SA, Muo M, Morrow CD (1991). Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif. J Virol 65: 4564-4572.
16. Joachims M, Breugel PC, Lloyd RE (1999). Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73: 718-727.
17. Kim DH, Gutin PH, Noble LJ, Nathan D, Yu JS, Nockels RP (1996). Treatment of genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. NeuroReport 7: 2221-2225.
18. Koch F, Koch G (1985). The molecular biology of poliovirus. Springer-Verlag: Vienna, pp 203-253.
19. Koike S, Taya C, Kurata T, Abe I, Ise I, Yonekawa H, Nomoto A (1991). Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 85: 951-955.
20. Mendelsohn CL, Wimmer E, Racaniello VR (1989). Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily Cell 56: 855-865.
21. Porter DC, Ansardi DC, Choi WS, Morrow CD (1993). Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 gag and pol proteins upon infection. J Virol 67: 3712-3719.
22. Porter DC, Ansardi DC, Morrow CD (1995). Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene using a complementation system which provides the P1 capsid protein in trans. J Virol 69: 1548-1555.
23. Porter DC, Ansardi DC, Wang J, McPherson S, Moldoveanu Z, Morrow CD (1998). Demonstration of the specificity of poliovirus encapsidation using novel replicon which encodes enzymatically active firefly luciferase. Virology 243: 1-11.
24. Ren R, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR (1990). Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63: 353-362.
25. Ren R, Racaniello VR (1992). Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 66: 296-304.
26. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei X-F, Achong MK (1998). IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320.